Почетна › Улцерозен колитис › Калифорнија
Клинички испитувања за Улцерозен колитис во Калифорнија
39 студии за Улцерозен колитис бараат учесници на локации во Калифорнија.
Градови во Калифорнија
- San Diego15 студии
- Los Angeles13 студии
- Mountain View8 студии
- Anaheim7 студии
- Lancaster7 студии
- Westminster5 студии
- Victorville4 студии
- San Francisco4 студии
- San Bernardino3 студии
- Sacramento3 студии
- Folsom3 студии
- Newport Beach3 студии
- Orange3 студии
- Oxnard3 студии
- Murrieta3 студии
- Garden Grove3 студии
- Chula Vista3 студии
Официјален текст на студијата (англиски)
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Clinnova Research /ID# 280509, Anaheim
- Southern California Res. Ctr /ID# 280476, Coronado
- Gastro Care Institute /ID# 281071, Lancaster
- и уште 2
Се регрутираФаза 2
Возраст од 18 до 75 · Сите полови · Ажурирано 5.10.2026 · NCT07697456Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- University of California Davis Comprehensive Cancer Center, Sacramento
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 5.10.2026 · NCT03816345A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
- Erick Alayo Medical Corp/Gastro SB Clinic, Chula Vista
- Southern California GI and Liver Centers (SCLC), Coronado
- Valley View Research, Garden Grove
- и уште 6
Се регрутираФаза 2
Возраст од 18 до 75 · Сите полови · Ажурирано 30.9.2026 · NCT06598943A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Gastroenterology and Liver Institute, Escondido
- United Clinical Research Institute, Murrieta
Се регрутираФаза 4
Возраст од 18 до 80 · Сите полови · Ажурирано 30.9.2026 · NCT06581328A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
- Rady Children's Hospital /ID# 271873, San Diego
- University of California San Francisco - Mission Bay /ID# 273022, San Francisco
Се регрутираФаза 3
Возраст од 2 до 17 · Сите полови · Ажурирано 30.9.2026 · NCT07071519A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
- Site US-018, San Diego
Се регрутираФаза 2
Возраст од 18 до 75 · Сите полови · Ажурирано 29.9.2026 · NCT07845487A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Site 024, Canoga Park
- Site 023, La Jolla
- Site 012, Lancaster
Се регрутираФаза 2
Возраст од 18 до 75 · Сите полови · Ажурирано 29.9.2026 · NCT07012395Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
- Xencor Investigative Site, Palo Alto
Се регрутираФаза 1/2Добредојдени се здрави волонтери
Возраст од 18 до 75 · Сите полови · Ажурирано 29.9.2026 · NCT06619990A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
- Gastro Care Institute, Lancaster
- Medical Associates Research Group, Inc., San Diego
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 28.9.2026 · NCT06979336A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)
- Clinnova Research ( Site 1042), Anaheim
- Southern California Research Center ( Site 1044), Coronado
Се регрутираФаза 2
Возраст од 18 до 75 · Сите полови · Ажурирано 28.9.2026 · NCT07463183A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
- Clinnova Research, Anaheim
- Southern California Research Center, Coronado
- Om Research LLC, Lancaster
- и уште 7
Се регрутираФаза 3
Возраст 12 и постари · Сите полови · Ажурирано 25.9.2026 · NCT07196748A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
- Loma Linda University Health System, Loma Linda
- Cedars-Sinai Medical Center, Los Angeles
- Lucile Packard Children's Hospital, Palo Alto
- и уште 1
Се регрутираФаза 2/3
Возраст од 2 до 17 · Сите полови · Ажурирано 24.9.2026 · NCT05076175Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Smart Cures Clinical Research, Anaheim
- Cedars-Sinai Medical Center, Beverly Hills
- United Medical Doctors - Los Alamitos, Los Alamitos
- и уште 1
Се регрутираФаза 3
Возраст од 18 до 70 · Сите полови · Ажурирано 24.9.2026 · NCT06937086LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- Clinnova Research, Anaheim
- GMC Clinical Research, Folsom
- Om Research LLC, Temple City
- и уште 1
Се регрутираФаза 2
Возраст од 18 до 80 · Сите полови · Ажурирано 22.9.2026 · NCT07415044A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- UCSF Medical Center at Mission Bay, San Francisco
Се регрутираФаза 3
Возраст од 2 до 19 · Сите полови · Ажурирано 22.9.2026 · NCT04844606A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
- Biopharma Informatic, LLC, Los Angeles
- Om Research LLC, Oxnard
Се регрутираФаза 2
Возраст од 18 до 80 · Сите полови · Ажурирано 22.9.2026 · NCT07483073LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
- Clinnova Research - Anaheim, Anaheim
- Om Research LLC, Lancaster
- Biopharma Informatic, LLC, Los Angeles
Се регрутираФаза 2
Возраст од 18 до 80 · Сите полови · Ажурирано 22.9.2026 · NCT07186101A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
- Cedars-Sinai Medical Center, Los Angeles
- Hoag Hospital Newport Beach, Newport Beach
Се регрутираФаза 4
Возраст од 18 до 65 · Сите полови · Ажурирано 21.9.2026 · NCT06095128A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Southern California GI & Liver Centers - Site Number: 8400062, Coronado
- United Medical Doctors CA - Site Number: 8400044, Murrieta
- Om Research, LLC - Victorville - Site Number: 8400022, Victorville
Се регрутираФаза 3
Возраст од 16 до 80 · Сите полови · Ажурирано 15.9.2026 · NCT07185009A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
- Clinnova Research, Anaheim
- Gastro SB Clinic, Chula Vista
- United Medical Doctors, Los Alamitos
- и уште 1
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 28.8.2026 · NCT07577856An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- FOMAT - Unio Specialty Care Arcadia - Site Number: 8400027, Arcadia
- Alliance Research Institute - Site Number: 8400008, Canoga Park
- Southern California GI & Liver Centers - Site Number: 8400062, Coronado
- и уште 13
Се регрутираФаза 3
Возраст од 16 до 80 · Сите полови · Ажурирано 20.8.2026 · NCT07184996Study to Evaluate the Efficacy and Safety of Ponesimod (VSP-128) in Patients With Moderately to Severely Active Ulcerative Colitis
- Vanda Investigational Site, Chula Vista
Се регрутираФаза 3
Возраст од 18 до 75 · Сите полови · Ажурирано 18.8.2026 · NCT07686081Functional Outcomes in Ulcerative Colitis Patients With Ileal Pouch Anal Anastomosis Treated With High Intensity Focused Electromagnetic Stimulation
- Cedars Sinai Medical Center, Los Angeles
Се регрутира
Возраст 18 и постари · Сите полови · Ажурирано 12.8.2026 · NCT07034443Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
- Hoag Hospital, Irvine
- UC San Diego Health, La Jolla
- Cedars-Sinai, Los Angeles
- и уште 1
Се регрутира
Возраст 18 и постари · Сите полови · Ажурирано 7.8.2026 · NCT05230173BOOM-IBD2 Pivotal Clinical Trial
- Gastroenterology Medical Clinic (Objective Health), Folsom
- Center for Colorectal Innovation, Los Angeles
- Hoag Hospital, Newport Beach
- и уште 1
Се регрутира
Возраст од 18 до 85 · Сите полови · Ажурирано 6.8.2026 · NCT06571669A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
- Children's Hospital Of Orange County, Orange
Се регрутираФаза 3
Возраст од 2 до 17 · Сите полови · Ажурирано 3.8.2026 · NCT06100289An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
- Scripps Clinic Torrey Pines, La Jolla
- United Medical Doctors, Los Alamitos
- United Medical Doctors, Los Alamitos
Се регрутираНабљудувачка студија
Возраст од 18 до 64 · Сите полови · Ажурирано 9.7.2026 · NCT06398626A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
- Valley View Wellness Medical Center, Garden Grove
- Loma Linda Children's Hospital, Loma Linda
- Loma Linda University Clinical Trial Center, Loma Linda
- и уште 7
Се регрутираФаза 2
Возраст од 12 до 17 · Сите полови · Ажурирано 8.7.2026 · NCT05287126A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Loma Linda University, Loma Linda
- Children's Hospital of Orange County, Orange
- Stanford Children's Health, Palo Alto
Се регрутираФаза 3
Возраст од 2 до 17 · Сите полови · Ажурирано 22.6.2026 · NCT06405087R-3750 in Patients With Mild to Moderate Ulcerative Colitis
- Amicis Research Center, Valencia
Се регрутираФаза 1
Возраст од 18 до 65 · Сите полови · Ажурирано 12.6.2026 · NCT05666960The Use of Butyrate Therapy in Pediatric Ulcerative Colitis
- Children's Hospital Los Angeles, Los Angeles
Се регрутираФаза 2
Возраст од 7 до 21 · Сите полови · Ажурирано 4.6.2026 · NCT05218850A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Rady Children's Hospital - San Diego - PIN, San Diego
Се регрутираФаза 3
Возраст 2 и постари · Сите полови · Ажурирано 7.5.2026 · NCT05442567Fermented Food-Supplemented Diet in Ulcerative Colitis
- Stanford University, Palo Alto
Се регрутира
Возраст 18 и постари · Сите полови · Ажурирано 27.2.2026 · NCT04401605The Influence of a Fasting Mimicking Diet on Ulcerative Colitis
- Stanford University, Palo Alto
Се регрутира
Возраст од 18 до 70 · Сите полови · Ажурирано 27.2.2026 · NCT03615690Impact of Prebiotics in Ulcerative Colitis
- UCLA, Los Angeles
Се регрутира
Возраст од 18 до 85 · Сите полови · Ажурирано 27.2.2026 · NCT06495658Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)
- University of Los Angeles Health, Los Angeles
Се регрутира
Возраст од 18 до 85 · Сите полови · Ажурирано 8.1.2026 · NCT05987852Effects of Pomegranate Juice on Ulcerative Colitis
- West Los Angeles VA Medical Center, Los Angeles
- UCLA Center for Human Nutrition, Los Angeles
Се регрутира
Возраст 18 и постари · Сите полови · Ажурирано 9.12.2025 · NCT07115862Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis
- Bausch Health Site 008, Garden Grove
Се регрутираФаза 4
Возраст од 5 до 17 · Сите полови · Ажурирано 16.9.2025 · NCT04314375Pharmacologic Weight Loss as Adjunct Therapy for Ulcerative Colitis in Obese Patients
- University of California San Diego, La Jolla
Се регрутираФаза 2
Возраст од 18 до 80 · Сите полови · Ажурирано 16.5.2023 · NCT04721873Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.